LODINE XL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lodine Xl, and when can generic versions of Lodine Xl launch?
Lodine Xl is a drug marketed by Wyeth Pharms Inc and is included in one NDA.
The generic ingredient in LODINE XL is etodolac. There are twenty-three drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the etodolac profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lodine Xl
A generic version of LODINE XL was approved as etodolac by ABRAXEOLUS on April 11th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LODINE XL?
- What are the global sales for LODINE XL?
- What is Average Wholesale Price for LODINE XL?
Summary for LODINE XL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 118 |
| Patent Applications: | 6,380 |
| DailyMed Link: | LODINE XL at DailyMed |
US Patents and Regulatory Information for LODINE XL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | LODINE XL | etodolac | TABLET, EXTENDED RELEASE;ORAL | 020584-001 | Oct 25, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Pharms Inc | LODINE XL | etodolac | TABLET, EXTENDED RELEASE;ORAL | 020584-003 | Jan 20, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Pharms Inc | LODINE XL | etodolac | TABLET, EXTENDED RELEASE;ORAL | 020584-002 | Oct 25, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LODINE XL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | LODINE XL | etodolac | TABLET, EXTENDED RELEASE;ORAL | 020584-001 | Oct 25, 1996 | ⤷ Sign Up | ⤷ Sign Up |
| Wyeth Pharms Inc | LODINE XL | etodolac | TABLET, EXTENDED RELEASE;ORAL | 020584-002 | Oct 25, 1996 | ⤷ Sign Up | ⤷ Sign Up |
| Wyeth Pharms Inc | LODINE XL | etodolac | TABLET, EXTENDED RELEASE;ORAL | 020584-003 | Jan 20, 1998 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LODINE XL
See the table below for patents covering LODINE XL around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Finland | 884245 | ⤷ Sign Up | |
| Ireland | 60311 | Sustained release etodolac | ⤷ Sign Up |
| Spain | 2021838 | DESCARGA ININTERRUMPIDA DE ETODOLAC | ⤷ Sign Up |
| United Kingdom | 2209940 | SUSTAINED RELEASE ETODOLAC | ⤷ Sign Up |
| Austria | 62132 | ⤷ Sign Up | |
| Mexico | 171463 | SISTEMA DE DOSIFICACION DE LIBERACION SOSTENIDA Y PROCEDIMIENTO PARA SU PREPARACION | ⤷ Sign Up |
| South Africa | 8807162 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
